(Q53956078)

22 May 2018

title

Effect of YM435, a novel dopamine DA1 receptor agonist, in a canine model of acute congestive heart failure. (English)

1 reference

22 May 2018

main subject

heart failure

0 references

congestive heart failure

1 reference

Yatsu T

1

1 reference

22 May 2018

Arai Y

2

1 reference

22 May 2018

Sudoh K

3

1 reference

22 May 2018

Shibasaki M

4

1 reference

22 May 2018

Uchida W

5

1 reference

22 May 2018

Inagaki O

6

1 reference

22 May 2018

Tanaka A

7

1 reference

22 May 2018

Takenaka T

8

1 reference

22 May 2018

publication date

1 May 1998

1 reference

22 May 2018

published in

General Pharmacology

1 reference

22 May 2018

volume

30

1 reference

22 May 2018

issue

5

1 reference

22 May 2018

page(s)

733-737

1 reference

22 May 2018

The beneficial effect of amrinone on acute drug-induced heart failure in the anaesthetised dog.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900340-6

7 January 2021

Synthesis, Resolution, and Renal Vasodilation Activity of Novel DA1 Agonists: 4-(3,4-Dihydroxyphenyl)-1,2,3,4-tetrahydroisoquinoline Derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900340-6

7 January 2021

4-(3,4-Dihydroxyphenyl)-1,2,3,4-tetrahydroisoquinoline derivatives. II. Their renal vasodilation activity and structure-activity relationship

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900340-6

7 January 2021

Physiology and pharmacology of cardiovascular catecholamine receptors: implications for treatment of chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900340-6

7 January 2021

The role of dopaminergic agents and the dopamine receptor in treatment for CHF.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900340-6

7 January 2021

Current therapy of the failing heart

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900340-6

7 January 2021

Neuroendocrine manifestations of congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900340-6

7 January 2021

Selective and nonselective dopamine receptor agonists: an innovative approach to cardiovascular disease treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900340-6

7 January 2021

Therapeutic applications of drugs acting on peripheral dopamine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900340-6

7 January 2021

Cardiovascular pharmacology of adrenergic and dopaminergic receptors: therapeutic significance in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900340-6

7 January 2021

Therapeutic options in the management of chronic heart failure. Is there a drug of first choice?

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900340-6

7 January 2021

Pathophysiology of chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900340-6

7 January 2021

Pathophysiology and current therapy of congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900340-6

7 January 2021

Experimental models of heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900340-6

7 January 2021

Effects of dopaminergic agents on cardiac and renal function in normal man and in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900340-6

7 January 2021

Dopamine DA1 receptor agonist activity of YM435 in the canine renal vasculature

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900340-6

7 January 2021

Hemodynamic characterization of YM435, a novel dopamine DA1 receptor agonist, in anesthetized dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900340-6

7 January 2021

Renal effect of YM435, a new dopamine D1 receptor agonist, in anesthetized dogs.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900340-6

7 January 2021

Pharmacological and pharmacokinetic characteristics of YM435, a novel dopamine DA1-receptor agonist, in anaesthetized dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0306-3623%2897%2900340-6

7 January 2021

10.1016/S0306-3623(97)00340-6

Identifiers

DOI

1 reference

22 May 2018

1 reference

22 May 2018